Literature DB >> 1562663

Epidemiological features of pertussis in the United States, 1980-1989.

K M Farizo1, S L Cochi, E R Zell, E W Brink, S G Wassilak, P A Patriarca.   

Abstract

From 1980 through 1989, 27,826 cases of pertussis were reported to the Centers for Disease Control, for an average annual crude incidence of 1.2 cases/100,000 population. The incidence of reported disease increased in all age groups during this period, but the increase was disproportionately large among adolescents and adults. Infants between 1 and 2 months of age were at highest risk for pertussis (average annual incidence, 62.8/100,000). Infants less than 2 months of age had the highest reported rates of pertussis-associated hospitalization (82%), pneumonia (25%), seizures (4%), encephalopathy (1%), and death (1%). Rates of complication were generally higher among unvaccinated children than among those who had received three or more doses of diphtheria-tetanus-pertussis vaccine; 64% of children 3 months to 4 years of age who had reported cases of pertussis had not been immunized appropriately for their age. Whereas control of pertussis in the United States may be further improved through increased levels of diphtheria-tetanus-pertussis vaccination among eligible infants and children, the use of acellular vaccines in adolescents and adults may also be needed to reduce the burden of pertussis in very young infants.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1562663     DOI: 10.1093/clinids/14.3.708

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  41 in total

1.  Adolescent and adult pertussis. A problem and a solution.

Authors:  R Schabas
Journal:  Can Fam Physician       Date:  2000-11       Impact factor: 3.275

2.  Reproducibility of Bordetella pertussis genomic DNA fragments generated by XbaI restriction and resolved by pulsed-field gel electrophoresis.

Authors:  Terri H Hardwick; Brian Plikaytis; Pamela K Cassiday; Gary Cage; Mark S Peppler; Deborah Shea; David Boxrud; Gary N Sanden
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

3.  Serious pertussis overlooked in infants.

Authors:  U Heininger; K Stehr; J D Cherry
Journal:  Eur J Pediatr       Date:  1992-05       Impact factor: 3.183

4.  The pneumoplex assays, a multiplex PCR-enzyme hybridization assay that allows simultaneous detection of five organisms, Mycoplasma pneumoniae, Chlamydia (Chlamydophila) pneumoniae, Legionella pneumophila, Legionella micdadei, and Bordetella pertussis, and its real-time counterpart.

Authors:  M Khanna; J Fan; K Pehler-Harrington; C Waters; P Douglass; J Stallock; S Kehl; K J Henrickson
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

5.  Patterns of susceptibility in an outbreak of Bordetella pertussis: evidence from a community-based study.

Authors:  David M Moore; Richard G Mathias
Journal:  Can J Infect Dis       Date:  2002-09

Review 6.  Pertussis vaccination for health care workers.

Authors:  Thomas J Sandora; Courtney A Gidengil; Grace M Lee
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

Review 7.  Diagnosis and management of pertussis.

Authors:  Alberto E Tozzi; Lucia Pastore Celentano; Marta Luisa Ciofi degli Atti; Stefania Salmaso
Journal:  CMAJ       Date:  2005-02-15       Impact factor: 8.262

8.  Contagious diseases in the United States from 1888 to the present.

Authors:  Willem G van Panhuis; John Grefenstette; Su Yon Jung; Nian Shong Chok; Anne Cross; Heather Eng; Bruce Y Lee; Vladimir Zadorozhny; Shawn Brown; Derek Cummings; Donald S Burke
Journal:  N Engl J Med       Date:  2013-11-28       Impact factor: 91.245

Review 9.  Prevention of pertussis through adult vaccination.

Authors:  Manika Suryadevara; Joseph B Domachowske
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

10.  Analysis of protective and nonprotective monoclonal antibodies specific for Bordetella pertussis lipooligosaccharide.

Authors:  R D Shahin; J Hamel; M F Leef; B R Brodeur
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.